20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Depreotide: A Non-Invasive Tool for Pulmonary Nodule Evaluation and Cancer Metastasis Imaging

NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of developing advanced diagnostic agents that improve healthcare outcomes. Depreotide is a prime example of such an agent, offering a non-invasive cancer imaging solution for critical oncological applications, particularly in the evaluation of pulmonary nodules and the detection of cancer metastases.

The challenge in diagnosing pulmonary nodules often lies in distinguishing between benign and malignant conditions without resorting to invasive procedures. Depreotide addresses this by acting as a specific somatostatin receptor imaging agent. Somatostatin receptors are frequently overexpressed on the surface of various cancer cells, including those found in lung tumors. By binding to these receptors, Depreotide allows for clear visualization of potential cancerous sites through nuclear imaging techniques. This targeted approach provides valuable data for malignant vs benign nodule assessment, guiding subsequent clinical decisions.

Beyond its use in assessing primary lung lesions, Depreotide also plays a significant role in identifying metastatic cancer that has spread to the lungs. For instance, in the context of renal cell carcinoma lung metastasis detection, Depreotide can help visualize these secondary tumors. Accurate identification of metastatic disease is crucial for staging the cancer and developing an effective treatment plan. The ability to perform this imaging non-invasively is a major advantage for patients.

The development of targeted diagnostic agents like Depreotide, which function as a peptide analog for lung nodules, represents a significant advancement in oncology. It empowers clinicians with more precise information, leading to better-informed treatment strategies and potentially improved patient prognoses. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying high-quality compounds that facilitate such critical diagnostic procedures and enhance the overall quality of cancer care.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Precision of Depreotide: A Guide to Somatostatin Receptor Imaging in Oncology

Next: The Crucial Role of Pharmaceutical Intermediates in Modern Drug Development

All Rights Reserved